Canopy Growth Corp

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Total Revenue $39.9m
$77.9m +95.38%
$226.3m +190.37%
$398.8m +76.18%
$546.6m +37.08%
$520.3m -4.82%
$402.9m -22.57%
$297.1m -26.25%
$269.0m -9.47%
$284.6m +5.80%
$293.6m +3.17%
Revenue from Contract with Customer, Including Assessed Tax $439.6m $607.2m $582.2m $450.9m $343.9m $314.0m $346.8m
Revenue From Interest ($110k)
Cost of Revenue $15.3m
$37.8m +147.11%
$175.4m +364.21%
$430.5m +145.38%
$479.7m +11.44%
$713.4m +48.72%
$507.0m -28.92%
$216.3m -57.35%
$189.5m -12.38%
$214.9m +13.43%
$219.8m +2.25%
Inventory production costs expensed to cost of sales $15.3m
$37.8m +147.11%
$175.4m +364.21%
Gross margin before the undernoted $24.6m $40.2m $50.9m
Gross margin $38.7m
$74.2m +91.64%
$88.9m +19.86%
($31.7m) -135.63%
$67.0m +311.34%
($193.1m) -388.31%
($104.1m) +46.06%
$80.9m +177.67%
$79.5m -1.70%
$69.7m -12.38%
$73.9m +6.03%
Gross Profit (derived) $24.6m
$74.2m +201.57%
$88.9m +19.86%
($31.7m) -135.63%
$67.0m +311.34%
($193.1m) -388.31%
($104.1m) +46.06%
$80.9m +177.67%
$79.5m -1.70%
$69.7m -12.38%
$73.9m +6.03%
Interest Income (Expense), Net ($9.6m) $12.2m
Research and Development Expense $810k $1.5m $15.2m $61.8m $57.6m $32.3m $21.7m $4.6m $2.7m $2.6m
Selling, General and Administrative Expense $693.7m $575.4m $472.8m $456.2m $229.4m $169.6m $160.0m $126.5m
Sales and marketing $13.0m $38.2m $154.4m
Amortization of Intangible Assets $51.3m $56.2m $38.2m $27.8m $24.8m $21.6m $17.4m
Operating Expenses $52.8m $156.5m $666.0m $1.6b $1.3b $889.6m $2.7b $309.6m $196.7m $231.3m $146.7m
Loss from operations ($14.1m)
($82.3m) -484.26%
($577.0m) -601.30%
Operating Income (Loss) $10.3m
($82.3m) -900.79%
($577.0m) -601.30%
($1.7b) -189.23%
($1.2b) +25.50%
($1.1b) +12.93%
($2.8b) -163.08%
($228.7m) +91.97%
($117.1m) +48.78%
($161.7m) -38.00%
($72.8m) +54.95%
Interest Expense $2.0m $6.7m $8.5m $103.9m $126.2m $105.4m $74.6m $38.2m $41.1m
Foreign Currency Transaction Gain (Loss), Realized ($1.2m) ($18.0m) $5.4m ($8.5m) $704k $1.5m ($624k)
Other Nonoperating Income (Expense) $224.3m ($387.9m) $753.3m ($466.0m) ($242.6m) ($479.9m) ($101.2m)
Income (Loss) from Equity Method Investments ($50k) ($1.5m) ($10.8m) ($64.4m) ($52.6m) ($100k)
Other Income $29.7m
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method ($50k) ($1.5m) ($10.8m)
Income (Loss) from Continuing Operations before Income Taxes, Domestic $10.3m $52.5m $657.8m ($1.2b) ($1.6b) ($163.9m) ($2.5b) ($280.8m) ($978.3m) ($184.7m) ($233.0m)
Loss before income taxes ($10.3m) ($52.5m) ($657.8m)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $10.3m $52.5m $657.8m ($1.5b) ($1.7b) ($329.4m) ($3.3b) ($471.4m) ($597.0m) ($262.9m) ($233.0m)
Current Tax Expense (Income) $2.7m $1.6m ($2.4m)
Deferred Tax Expense (Income) $2.7m $1.6m ($9.9m)
Current Income Tax Expense (Benefit) $2.7m $1.6m $12.3m $16.7m $21.4m ($2.4m) ($4.1m) $268k $339k ($13k) ($397k)
Income Tax Expense (Benefit) $2.7m $1.6m $12.3m ($121.6m) ($13.1m) ($8.9m) ($4.8m) $12.3m $7.1m $23k ($397k)
Net loss ($7.6m) ($54.1m) ($670.1m)
Net Income (Loss) Attributable to Parent ($50k)
$16.2m +32538.00%
$15.3m -5.39%
($1.3b) -8711.35%
($1.7b) -32.06%
($302.2m) +82.68%
($3.3b) -984.83%
($657.3m) +79.95%
($598.1m) +9.00%
($262.9m) +56.04%
($232.6m) +11.52%
Net Income (Loss) Attributable to Noncontrolling Interest ($66.1m) $74.1m ($18.3m) ($31.4m) ($232.6m)
Income (Loss) from Continuing Operations, Per Basic Share ($6) ($6) ($1)
Income (Loss) from Continuing Operations, Per Diluted Share ($6) ($6) ($1)
Earnings Per Share, Basic ($0.06) ($0.40) ($2.57) ($3.80) ($7.07) ($8.79) ($5.56) ($0.88) ($0.67)
Earnings Per Share, Diluted ($0.06) ($0.40) ($2.57) ($3.80) ($7.07) ($8.79) ($5.56) ($0.88) ($0.67)
Weighted Average Number of Shares Outstanding, Basic 463.7m 74.8m 107.6m 298.0m 356.5m
Weighted average number of outstanding common shares: 119.0m 177.3m 267.0m
Weighted Average Number of Shares Outstanding, Diluted 463.7m 74.8m 107.6m 298.0m 356.5m
Additional Financial Items
Administrative Expense $6.5m
Applicable Tax Rate $0 $0
Depreciation And Amortisation Expense $20.5m $21.5m $20.2m
Employee Benefits Expense $50.0m
Goodwill, Impairment Loss $40.7m $1.8b $42.1m $47.5m
Professional Fees Expense $10.4m
Profit Loss Attributable To Noncontrolling Interests $16.2m $15.3m
Profit Loss Attributable To Owners Of Parent ($685.4m)
Profit Loss Before Tax ($52.5m) ($657.8m)
Profit Loss From Operating Activities ($82.3m) ($577.0m)
Fair value changes in biological assets included in inventory sold and other inventory charges $35.0m $66.3m $129.5m
Unrealized gain on changes in fair value of biological assets ($49.1m) ($100.3m) ($167.6m)
General and administration $16.9m $43.8m $168.4m
Acquisition-related costs $7.4m $3.4m $23.4m
Share-based compensation expense $8.0m $29.6m $182.8m
Share-based compensation expense related to acquisition milestones $690k $19.5m $100.2m
Depreciation and amortization $6.1m $20.5m $21.5m $20.2m
Share of loss on equity investments ($50k) ($1.5m) ($10.8m)
Other (expense) income, net $3.9m $31.2m ($70.0m)
Canopy Growth Corporation ($7.5m) ($70.4m) ($685.4m)
Non-controlling interests ($51k) $16.2m $15.3m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($483.7m) ($604.1m) ($262.9m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($192.1m) $6.0m $0
Net Foreign Exchange Loss $5.6m
Total other (expense) income, net $29.7m ($80.7m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.